aod9604 fda Fat burner, growth hormone drugs recalled over product sterility concerns AOD9604 PEPTIDE 2MG/5MG VIAL –
AOD9604 PEPTIDE 2MG 5MG VIAL UMBRELLA Labs The FDA has repeatedly flagged AOD 9604 as a compound of concern. It was placed on the Category 2 list in 2023 bulk drug substances in compounding that may present significant FDA's Overreach on Compounded Peptides AOD9604 PEPTIDE LIQUID SPRAY 15ML BOTTLE UMBRELLA Labs
Pay in 4 interest-free payments of $6.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6


